» Articles » PMID: 17535907

A High-throughput SiRNA Library Screen Identifies Osteogenic Suppressors in Human Mesenchymal Stem Cells

Overview
Specialty Science
Date 2007 May 31
PMID 17535907
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue-specific (or adult) stem/progenitor cells are regarded as the source for normal tissue homeostasis and tissue repair. They also provide tremendous promise for regenerative medicine because of their capacity to proliferate and differentiate into a variety of mature cell types. Human mesenchymal stem cells (hMSCs) can differentiate into osteocytes, adipocytes, chondrocytes, muscle cells, and neurons. However, the molecular mechanisms underlying these differentiation processes are poorly understood. We screened a synthetic siRNA library targeting 5,000 human genes to identify the endogenous repressors of osteogenic specification, which when silenced could initiate differentiation of hMSCs into osteoblasts. This screen yielded 53 candidate suppressors, and 12 of those were further confirmed for their dynamic roles in suppressing osteogenic specification in hMSCs. Furthermore, cAMP was identified to play opposing roles in osteogenesis vs. adipogenesis. This study provides a basis for further elucidation of the genetic network controlling osteogenesis and, potentially, the molecular rationale for treating bone diseases.

Citing Articles

Role of ubiquitination in the occurrence and development of osteoporosis (Review).

Fan X, Zhang R, Xu G, Fan P, Luo W, Cai C Int J Mol Med. 2024; 54(2).

PMID: 38940355 PMC: 11232666. DOI: 10.3892/ijmm.2024.5392.


Osteoporosis therapy using nanoparticles: a review.

Zeghoud S, Ben Amor I, Alnazza Alhamad A, Darwish L, Hemmami H Ann Med Surg (Lond). 2024; 86(1):284-291.

PMID: 38222677 PMC: 10783367. DOI: 10.1097/MS9.0000000000001467.


Lipid nanoparticle-mediated silencing of osteogenic suppressor GNAS leads to osteogenic differentiation of mesenchymal stem cells in vivo.

Basha G, Cottle A, Pretheeban T, Chan K, Witzigmann D, Young R Mol Ther. 2022; 30(9):3034-3051.

PMID: 35733339 PMC: 9481989. DOI: 10.1016/j.ymthe.2022.06.012.


Cell-Based Double-Screening Method to Identify a Reliable Candidate for Osteogenesis-Targeting Compounds.

Fukuyasu S, Kayashima H, Moribayashi A, Matsuoka S, Nagasaki A, Okawa H Biomedicines. 2022; 10(2).

PMID: 35203635 PMC: 8962348. DOI: 10.3390/biomedicines10020426.


E3 Ubiquitin Ligase-Mediated Regulation of Osteoblast Differentiation and Bone Formation.

Shen J, Fu B, Li Y, Wu Y, Sang H, Zhang H Front Cell Dev Biol. 2021; 9:706395.

PMID: 34513836 PMC: 8430030. DOI: 10.3389/fcell.2021.706395.


References
1.
Foulkes N, Borrelli E, Sassone-Corsi P . CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell. 1991; 64(4):739-49. DOI: 10.1016/0092-8674(91)90503-q. View

2.
Acampora D, Merlo G, Paleari L, Zerega B, Postiglione M, Mantero S . Craniofacial, vestibular and bone defects in mice lacking the Distal-less-related gene Dlx5. Development. 1999; 126(17):3795-809. DOI: 10.1242/dev.126.17.3795. View

3.
Paddison P, Caudy A, Bernstein E, Hannon G, Conklin D . Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 2002; 16(8):948-58. PMC: 152352. DOI: 10.1101/gad.981002. View

4.
Lee N, Dohjima T, Bauer G, Li H, Li M, Ehsani A . Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol. 2002; 20(5):500-5. DOI: 10.1038/nbt0502-500. View

5.
Fire A, Xu S, Montgomery M, Kostas S, Driver S, Mello C . Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998; 391(6669):806-11. DOI: 10.1038/35888. View